Histopathological and molecular study from EUS fine-needle biopsy of a programmed cell death ligand 1 positive, KRAS mutated pancreatic metastasis

Por Tournier, Quentin, Casteillo, François, Bayle-Bleuez, Sophie, Phelip, Jean-Marc, Williet, Nicolas
Publicado no Endosc Ultrasound (2020)

First Characterization with Ultrasound Contrast Agent of a Fibrovascular Polyp Before Its Endoscopic Resection: A Case Report (with Videos)

Por Williet, Nicolas, Kassir, Radwan, Casteillo, Francois, Yvorel, Violaine, Habougit, Cyril, Roblin, Xavier, Phelip, Jean-Marc
Publicado no Clin Endosc (2019)

Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer

Por Phelip, Jean Marc, Bageacu, Serban, Baconnier, Mathieu, Barabino, Gabriele, Del Tedesco, Emilie, Benhamou, Pierre Yves, Roblin, Xavier
Publicado em 2011

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pan...

Por Williet, Nicolas, Di Bernardo, Thomas, Vernet, Chloé, Roche, Léa Saban, Muron, Thierry, Roblin, Xavier, Magne, Nicolas, Phelip, Jean-Marc
Publicado no Oncotarget (2018)

Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literature

Por Williet, Nicolas, Kassir, Radwan, Cuilleron, Muriel, Dumas, Olivier, Rinaldi, Leslie, Augeul-Meunier, Karine, Cottier, Michèle, Roblin, Xavier, Phelip, Jean-Marc
Publicado no World J Clin Oncol (2017)

The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker

Por Williet, Nicolas, Petcu, Carmen Adina, Rinaldi, Leslie, Cottier, Michèle, Del Tedesco, Emilie, Clavel, Léa, Dumas, Olivier, Jarlot, Camille, Bouarioua, Nadia, Roblin, Xavier, Peoc’h, Michel, Phelip, Jean-Marc
Publicado no Oncotarget (2017)

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Por Di Fiore, Frederic, Bouché, Olivier, Lepage, Come, Sefrioui, David, Gangloff, Alice, Schwarz, Lilian, Tuech, Jean Jacques, Aparicio, Thomas, Lecomte, Thierry, Boulagnon-Rombi, Camille, Lièvre, Astrid, Manfredi, Sylvain, Phelip, Jean Marc, Michel, Pierre
Publicado no Dig Liver Dis (2020)

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

Por Bachet, Jean-Baptiste, Wyrwicz, Lucjan, Price, Timothy, Cremolini, Chiara, Phelip, Jean-Marc, Portales, Fabienne, Ozet, Ahmet, Cicin, Irfan, Atlan, Dan, Becquart, Martin, Vidot, Loick, Mounedji, Nadjat, Van Cutsem, Eric, Taieb, Julien, Falcone, Alfredo
Publicado no ESMO Open (2020)

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised...

Por Dahan, Laetitia, Bonnetain, Frank, Ychou, Marc, Mitry, Emmanuel, Gasmi, Mohamed, Raoul, Jean-Luc, Cattan, Stéphane, Phelip, Jean-Marc, Hammel, Pascal, Chauffert, Bruno, Michel, Pierre, Legoux, Jean-Louis, Rougier, Philippe, Bedenne, Laurent, Seitz, Jean-François
Publicado em 2010

Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey

Por Langrand-Escure, Julien, Diao, Peng, Garcia, Max-Adrien, Wang, Guoping, Guy, Jean-Baptiste, Espenel, Sophie, Guillaume, Elodie, Rehailia-Blanchard, Amel, Pigné, Grégoire, de Laroche, Guy, Kaczmarek, David, Muron, Thierry, Porcheron, Jack, Phelip, Jean-Marc, Vallard, Alexis, Magné, Nicolas
Publicado no Sci Rep (2018)

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker

Por Vallard, Alexis, Garcia, Max-Adrien, Diao, Peng, Espenel, Sophie, de Laroche, Guy, Guy, Jean-Baptiste, Mrad, Majed Ben, Rancoule, Chloé, Kaczmarek, David, Muron, Thierry, Pigné, Gregoire, Porcheron, Jack, Peoc'h, Michel, Phelip, Jean-Marc, Langrand -Escure, Julien, Magné, Nicolas
Publicado no Oncotarget (2018)

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Por Williet, Nicolas, Saint, Angélique, Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Bechade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Desrame, Jérome, Artru, Pascal, Thirot Bidault, Anne, Le Roy, Bertrand, Pezet, Denis, Phelip, Jean-Marc, Taieb, Julien
Publicado no Therap Adv Gastroenterol (2019)

Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial

Por Aparicio, Thomas, Bennouna, Jaafar, Le Malicot, Karine, Boige, Valérie, Taieb, Julien, Bouché, Olivier, Phelip, Jean-Marc, François, Eric, Borel, Christian, Faroux, Roger, Dahan, Laetitia, Bachet, Jean-Baptiste, Egreteau, Joelle, Kaminsky, Marie-Christine, Gornet, Jean-Marc, Cojocarasu, Oana, Gasmi, Mohamed, Guerin-Meyer, Véronique, Lepage, Côme, Ghiringhelli, François
Publicado no Br J Cancer (2020)

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

Por Chau, Ian, Park, Joon Oh, Ryoo, Baek-Yeol, Yen, Chia-Jui, Poon, Ronnie, Pastorelli, Davide, Blanc, Jean-Frédéric, Kudo, Masatoshi, Pfiffer, Tulio, Hatano, Etsuro, Chung, Hyun Cheol, Kopeckova, Katerina, Phelip, Jean-Marc, Brandi, Giovanni, Ohkawa, Shinichi, Li, Chung-Pin, Okusaka, Takuji, Hsu, Yanzhi, Abada, Paolo B., Zhu, Andrew X.
Publicado no Br J Cancer (2018)

Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT S...

Por Palmieri, Lola‐Jade, Mineur, Laurent, Tougeron, David, Rousseau, Benoît, Granger, Victoire, Gornet, Jean‐Marc, Smith, Denis, Lievre, Astrid, Galais, Marie‐Pierre, Doat, Solene, Pernot, Simon, Bignon‐Bretagne, Anne‐Laure, Metges, Jean‐Philippe, Baba‐Hamed, Nabil, Michel, Pierre, Obled, Stéphane, Vitellius, Carole, Bouche, Olivier, Saban‐Roche, Léa, Buecher, Bruno, des Guetz, Gaëtan, Locher, Christophe, Trouilloud, Isabelle, Goujon, Gaël, Dior, Marie, Manfredi, Sylvain, Soularue, Emilie, Phelip, Jean‐Marc, Henriques, Julie, Vernery, Dewi, Coriat, Romain
Publicado no Oncologist (2019)